» Articles » PMID: 32565825

Ginsenoside Rg1 Improves Differentiation by Inhibiting Senescence of Human Bone Marrow Mesenchymal Stem Cell Via GSK-3 and -Catenin

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2020 Jun 23
PMID 32565825
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To demonstrate the effect of Ginsenoside Rg1 on the differentiation of human bone marrow-derived mesenchymal stem cells (hBM-MSCs). Subsequently, a rational mechanism for the detection of Rg1 which affects mesenchymal stem cell differentiation was explored.

Methods: Flow cytometry is used for cell identification. The differentiation ability of hBM-MSCs was studied by differentiation culture. SA--gal staining is used to detect cell senescence levels. Western blot and immunofluorescence were used to determine protein expression levels. RT-qPCR is used to detect mRNA expression levels.

Results: Rg1 regulates the differentiation of hBM-MSCs. Differentiation culture analysis showed that Rg1 promoted cells to osteogenesis and chondrogenesis. Western blot results showed that Rg1 regulated the overactivation of the -catenin signaling pathway and significantly adjusted the phosphorylation of GSK-3. GSK-3 inhibitor (Licl) significantly increased Rg1-induced phosphorylation of GSK-3, which in turn reduced Rg1-induced differentiation of hBM-MSCs.

Conclusion: Ginsenoside Rg1 can reduce the excessive activation of the Wnt pathway in senescent cells by inhibiting the phosphorylation of GSK-3 and regulate the mesenchymal stem cell differentiation ability.

Citing Articles

Ginsenoside Re promotes proliferation of murine bone marrow mesenchymal stem cells in vitro through estrogen-like action.

Luo L, Peng B, Xiong L, Wang B, Wang L In Vitro Cell Dev Biol Anim. 2024; 60(9):996-1008.

PMID: 39256290 DOI: 10.1007/s11626-024-00969-1.


Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.

Cheng W, Zhang B, Chen N, Liu Q, Ma X, Fu X Cell Biochem Biophys. 2024; 82(2):1433-1451.

PMID: 38753250 DOI: 10.1007/s12013-024-01297-7.


Ginsenosides on stem cells fate specification-a novel perspective.

Liu Y, Jiang L, Song W, Wang C, Yu S, Qiao J Front Cell Dev Biol. 2023; 11:1190266.

PMID: 37476154 PMC: 10354371. DOI: 10.3389/fcell.2023.1190266.


Strategies for tissue engineering of vascularized bone regeneration (Review).

He Y, Liang L, Luo C, Zhang Z, Huang J Biomed Rep. 2023; 18(6):42.

PMID: 37325184 PMC: 10265129. DOI: 10.3892/br.2023.1625.


Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review.

Fonseca L, Bolivar-Mona S, Agudelo T, Beltran L, Camargo D, Correa N Heliyon. 2023; 9(2):e13464.

PMID: 36865479 PMC: 9970931. DOI: 10.1016/j.heliyon.2023.e13464.


References
1.
Castaneda A, Serrano C, Hernandez-Trejo J, Gutierrez-Martinez I, Montejo-Lopez W, Gomez-Suarez M . pVHL suppresses Akt/β-catenin-mediated cell proliferation by inhibiting 14-3-3ζ expression. Biochem J. 2017; 474(16):2679-2689. DOI: 10.1042/BCJ20161097. View

2.
Li J, Yang C, Zhang S, Liu S, Zhao L, Luo H . Ginsenoside Rg1 inhibits inflammatory responses via modulation of the nuclear factor‑κB pathway and inhibition of inflammasome activation in alcoholic hepatitis. Int J Mol Med. 2017; 41(2):899-907. PMC: 5752168. DOI: 10.3892/ijmm.2017.3297. View

3.
Shang Z . [Kou Zongshi and his Amplification of classics of Shen Nong's Herbal] (Chi). Zhonghua Yi Shi Za Zhi. 1984; 14(3):146-9. View

4.
Zhang Z, Nor F, Oh M, Cucco C, Shi S, Nor J . Wnt/β-Catenin Signaling Determines the Vasculogenic Fate of Postnatal Mesenchymal Stem Cells. Stem Cells. 2016; 34(6):1576-87. PMC: 5338744. DOI: 10.1002/stem.2334. View

5.
Zu G, Guo J, Che N, Zhou T, Zhang X, Wang G . Protective effects of ginsenoside Rg1 on intestinal ischemia/reperfusion injury-induced oxidative stress and apoptosis via activation of the Wnt/β-catenin pathway. Sci Rep. 2016; 6:38480. PMC: 5133596. DOI: 10.1038/srep38480. View